Advertisement

Spinal Cannabinoid Receptor Type 2 Agonist Reduces Mechanical Allodynia and Induces Mitogen-Activated Protein Kinase Phosphatases in a Rat Model of Neuropathic Pain

Published:August 16, 2012DOI:https://doi.org/10.1016/j.jpain.2012.05.013

      Abstract

      Peripheral nerve injury generally results in spinal neuronal and glial plastic changes associated with chronic behavioral hypersensitivity. Spinal mitogen-activated protein kinases (MAPKs), eg, p38 or extracellular signal-regulated kinases (ERKs), are instrumental in the development of chronic allodynia in rodents, and new p38 inhibitors have shown potential in acute and neuropathic pain patients. We have previously shown that the cannabinoid type 2 receptor agonist JWH015 inhibits ERK activity by inducing MAPK phosphatase (MKP)-1 and MKP-3 (the major regulators of MAPKs) in vitro in microglial cells. Therefore, we decided to investigate the role of these phosphatases in the mechanisms of action of JWH015 in vivo using the rat L5 nerve transection model of neuropathic pain. We observed that peripheral nerve injury reduced spinal MKP-1/3 expression and activity and that intrathecal JWH015 reduced established L5 nerve injury-induced allodynia, enhanced spinal MKP-1/3 expression and activity, and reduced the phosphorylated form of p38 and ERK-1/2. Triptolide, a pharmacological blocker of MKP-1 and MKP-3 expression, inhibited JWH015’s effects, suggesting that JWH015 exerts its antinociceptive effects by modulating MKP-1 and MKP-3. JWH015-induced antinociception and MKP-1 and MKP-3 expression were inhibited by the cannabinoid type 2 receptor antagonist AM630. Our data suggest that MKP-1 and MKP-3 are potential targets for novel analgesic drugs.

      Perspective

      MAPKs are pivotal in the development of chronic allodynia in rodent models of neuropathic pain. A cannabinoid type 2 receptor agonist, JWH015, reduced neuropathic allodynia in rats by reducing MAPK phosphorylation and inducing spinal MAPK phosphatases 1 and 3, the major regulators of MAPKs.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abraham S.M.
        • Lawrence T.
        • Kleiman A.
        • Warden P.
        • Medghalchi M.
        • Tuckermann J.
        • Saklatvala J.
        • Clark A.R.
        Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.
        J Exp Med. 2006; 203: 1883-1889
      1. Alkaitis MS, Ndong C, Landry RP, DeLeo JA, A. R-SE: Reduced Antinociceptive Effect of Repeated Treatment with a Cannabinoid Receptor Type 2 Agonist in Cannabinoid-Tolerant Rats Following Spinal Nerve Transection. In: Pain Management - Current Issues and Opinions (Racz, G.B. and Noe, C.E., Eds.), InTech, 2012, pp. 101-122. Available from: http://www.intechopen.com/books/pain-management-current-issues-and-opinions/reduced-antinociceptive-effect-of-repeated-treatment-with-a-cannabinoid-receptor-type-2-agonist-in-c

        • Alkaitis M.S.
        • Solorzano C.
        • Landry R.P.
        • Piomelli D.
        • DeLeo J.A.
        • Romero-Sandoval E.A.
        Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain.
        PLoS One. 2010; 5: e10891
        • Anand P.
        • Shenoy R.
        • Palmer J.E.
        • Baines A.J.
        • Lai R.Y.
        • Robertson J.
        • Bird N.
        • Ostenfeld T.
        • Chizh B.A.
        Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.
        Eur J Pain. 2011; 15: 1040-1048
        • Bani-Hashem N.
        • Hassan-Nasab B.
        • Pour E.A.
        • Maleh P.A.
        • Nabavi A.
        • Jabbari A.
        Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery.
        Saudi J Anaesth. 2011; 5: 382-386
        • Chang L.
        • Luo L.
        • Palmer J.A.
        • Sutton S.
        • Wilson S.J.
        • Barbier A.J.
        • Breitenbucher J.G.
        • Chaplan S.R.
        • Webb M.
        Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
        Br J Pharmacol. 2006; 148: 102-113
        • Chaplan S.R.
        • Bach F.W.
        • Pogrel J.W.
        • Chung J.M.
        • Yaksh T.L.
        Quantitative assessment of tactile allodynia in the rat paw.
        J Neurosci Methods. 1994; 53: 55-63
        • Eljaschewitsch E.
        • Witting A.
        • Mawrin C.
        • Lee T.
        • Schmidt P.M.
        • Wolf S.
        • Hoertnagl H.
        • Raine C.S.
        • Schneider-Stock R.
        • Nitsch R.
        • Ullrich O.
        The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
        Neuron. 2006; 49: 67-79
        • Gong Y.
        • Xue B.
        • Jiao J.
        • Jing L.
        • Wang X.
        Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia.
        J Neurochem. 2008; 107: 779-788
        • Gozdz A.
        • Vashishta A.
        • Kalita K.
        • Szatmari E.
        • Zheng J.J.
        • Tamiya S.
        • Delamere N.A.
        • Hetman M.
        Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases.
        J Neurochem. 2008; 106: 2056-2067
        • Hagg S.
        • Alserius T.
        • Noori P.
        • Ruusalepp A.
        • Ivert T.
        • Tegner J.
        • Bjorkegren J.
        • Skogsberg J.
        Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting.
        Int J Mol Med. 2011; 27: 851-857
        • Hamm A.
        • Krott N.
        • Breibach I.
        • Blindt R.
        • Bosserhoff A.K.
        Efficient transfection method for primary cells.
        Tissue Eng. 2002; 8: 235-245
        • Huang H.
        • Fan S.
        • Ji X.
        • Zhang Y.
        • Bao F.
        • Zhang G.
        Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK.
        J Int Med Res. 2009; 37: 511-519
        • Jeffrey K.L.
        • Camps M.
        • Rommel C.
        • Mackay C.R.
        Targeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses.
        Nat Rev Drug Discov. 2007; 6: 391-403
        • Ji R.R.
        • Gereau IV, R.W.
        • Malcangio M.
        • Strichartz G.R.
        MAP kinase and pain.
        Brain Res Rev. 2009; 60: 135-148
        • Jin S.X.
        • Zhuang Z.Y.
        • Woolf C.J.
        • Ji R.R.
        p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain.
        J Neurosci. 2003; 23: 4017-4022
        • Jin Y.
        • Hu D.
        • Peterson E.L.
        • Eng C.
        • Levin A.M.
        • Wells K.
        • Beckman K.
        • Kumar R.
        • Seibold M.A.
        • Karungi G.
        • Zoratti A.
        • Gaggin J.
        • Campbell J.
        • Galanter J.
        • Chapela R.
        • Rodriguez-Santana J.R.
        • Watson H.G.
        • Meade K.
        • Lenoir M.
        • Rodriguez-Cintron W.
        • Avila P.C.
        • Lanfear D.E.
        • Burchard E.G.
        • Williams L.K.
        Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.
        J Allergy Clin Immunol. 2010; 126 (e611-612): 618-625
        • Karbarz M.J.
        • Luo L.
        • Chang L.
        • Tham C.S.
        • Palmer J.A.
        • Wilson S.J.
        • Wennerholm M.L.
        • Brown S.M.
        • Scott B.P.
        • Apodaca R.L.
        • Keith J.M.
        • Wu J.
        • Breitenbucher J.G.
        • Chaplan S.R.
        • Webb M.
        Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
        Anesth Analg. 2009; 108: 316-329
        • Kawakami Y.
        • Rodriguez-Leon J.
        • Koth C.M.
        • Buscher D.
        • Itoh T.
        • Raya A.
        • Ng J.K.
        • Esteban C.R.
        • Takahashi S.
        • Henrique D.
        • Schwarz M.F.
        • Asahara H.
        • Izpisua Belmonte J.C.
        MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb.
        Nat Cell Biol. 2003; 5: 513-519
        • Kawasaki Y.
        • Kohno T.
        • Zhuang Z.Y.
        • Brenner G.J.
        • Wang H.
        • Van Der Meer C.
        • Befort K.
        • Woolf C.J.
        • Ji R.R.
        Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization.
        J Neurosci. 2004; 24: 8310-8321
        • Kawasaki Y.
        • Xu Z.Z.
        • Wang X.
        • Park J.Y.
        • Zhuang Z.Y.
        • Tan P.H.
        • Gao Y.J.
        • Roy K.
        • Corfas G.
        • Lo E.H.
        • Ji R.R.
        Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain.
        Nat Med. 2008; 14: 331-336
        • Kim Y.
        • Rice A.E.
        • Denu J.M.
        Intramolecular dephosphorylation of ERK by MKP3.
        Biochemistry. 2003; 42: 15197-15207
        • Kizjakina K.
        • Bryson J.M.
        • Grandinetti G.
        • Reineke T.M.
        Cationic glycopolymers for the delivery of pDNA to human dermal fibroblasts and rat mesenchymal stem cells.
        Biomaterials. 2012; 33: 1851-1862
        • Klongnoi B.
        • Kaewpradub P.
        • Boonsiriseth K.
        • Wongsirichat N.
        Effect of single dose preoperative intramuscular dexamethasone injection on lower impacted third molar surgery.
        Int J Oral Maxillofac Surg. 2012; 41: 376-379
        • Korhonen R.
        • Turpeinen T.
        • Taimi V.
        • Nieminen R.
        • Goulas A.
        • Moilanen E.
        Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase.
        Mol Immunol. 2011; 48: 2059-2068
        • Li G.L.
        • Winter H.
        • Arends R.
        • Jay G.W.
        • Le V.
        • Young T.
        • Huggins J.P.
        Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.
        Br J Clin Pharmacol. 2012; 73: 706-716
        • Manetsch M.
        • Che W.
        • Seidel P.
        • Chen Y.
        • Ammit A.J.
        MKP-1: A negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.
        Cell Signal. 2012; 24: 907-913
        • Ndong C.
        • Landry R.P.
        • Deleo J.A.
        • Romero-Sandoval E.A.
        Mitogen activated protein kinase phosphatase-1 prevents the development of tactile sensitivity in a rodent model of neuropathic pain.
        Mol Pain. 2012; 8: 34
        • Oride A.
        • Kanasaki H.
        • Purwana I.N.
        • Miyazaki K.
        Possible involvement of mitogen-activated protein kinase phosphatase-1 (MKP-1) in thyrotropin-releasing hormone (TRH)-induced prolactin gene expression.
        Biochem Biophys Res Commun. 2009; 382: 663-667
        • Romero-Sandoval A.
        • Nutile-McMenemy N.
        • DeLeo J.A.
        Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury.
        Anesthesiology. 2008; 108: 722-734
        • Romero-Sandoval E.A.
        • Horvath R.
        • Landry R.P.
        • DeLeo J.A.
        Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.
        Mol Pain. 2009; 5: 25
        • Russo R.
        • Loverme J.
        • La Rana G.
        • Compton T.R.
        • Parrott J.
        • Duranti A.
        • Tontini A.
        • Mor M.
        • Tarzia G.
        • Calignano A.
        • Piomelli D.
        The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
        J Pharmacol Exp Ther. 2007; 322: 236-242
        • Shipp L.E.
        • Lee J.V.
        • Yu C.Y.
        • Pufall M.
        • Zhang P.
        • Scott D.K.
        • Wang J.C.
        Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids.
        PLoS One. 2010; 5: e13754
        • Srivastava N.
        • Sudan R.
        • Saha B.
        CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
        J Immunol. 2011; 186: 5863-5872
        • Tong S.E.
        • Daniels S.E.
        • Black P.
        • Chang S.
        • Protter A.
        • Desjardins P.J.
        Novel p38alpha Mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain.
        J Clin Pharmacol. 2012; 52: 717-728
        • Toth C.C.
        • Jedrzejewski N.M.
        • Ellis C.L.
        • Frey II, W.H.
        Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
        Mol Pain. 2010; 6: 16
        • Wen Y.R.
        • Suter M.R.
        • Ji R.R.
        • Yeh G.C.
        • Wu Y.S.
        • Wang K.C.
        • Kohno T.
        • Sun W.Z.
        • Wang C.C.
        Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia.
        Anesthesiology. 2009; 110: 155-165
        • Zhao Q.
        • Shepherd E.G.
        • Manson M.E.
        • Nelin L.D.
        • Sorokin A.
        • Liu Y.
        The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: Attenuation of proinflammatory cytokine biosynthesis via feedback control of p38.
        J Biol Chem. 2005; 280: 8101-8108
        • Zhou Y.
        • Ling E.A.
        • Dheen S.T.
        Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
        J Neurochem. 2007; 102: 667-678